ACTC CARDIFF promises to be a great event with a scientific programme lined up with something for everyone, whether you're a PhD student, Post Doc, Primary investigator or Professor, Research Scientist, Senior Scientist, Scientific Manager or Department Director.


Tuesday 4th June


Advanced Cell Culture; 3D, Fluid Flow & Co-culture

Ms Lekha Shah (University of Manchester)

Tumour progression in metastatic breast cancer cell lines: engineered in vitro models

Dr. ir. Eirini Velliou (University of Surrey)

Engineering a novel versatile 3D tool for accelerating cancer therapies from bench to bed: A case study on pancreatic cancer

Ms Lauren Hyndman (University of Glasgow)

Mathematical modelling to guide experimental protocols for in vitro drug testing

KEYNOTE: Professor Marilena Loizidou (University College London)

Tumouroids: complex 3d cancer mimetics for the assessment of drug efficacy




KEYNOTE: Dr Uwe Marx (TissUse GmbH)

From organ-on-a-chip tools towards patients on chips – enforcing a paradigm shift in drug development

Dr Anwar Palakkan (University of Edinburgh)

Embryonic stem cell derived anatomically realistic kidney organoids

Professor Aline Miller (University of Manchester)

Engineering 3D Physiological Models and Cell Scaffolds using Self-Assembling Peptides; from lab to commercialisation

Dr Elisa Moschini (Luxembourg Institute of Science and Technology)

3D-tetraculture system at the air-liquid interface as a valuable tool for respiratory irritation and inflammation: case study using different silver-based nanomaterials


13:00: LUNCH


Dr Elisa Budyn (Ecole Normale Superieure de Cachan)

3D bone self-assembly in a bone-on-chip
Dr Victoria Kearns (University of Liverpool)

Development of Complementary in vitro and computational models of Drug Delivery Across the Outer Blood-Retinal Barrier
Ms Abigail Martin (University of Hertfordshire)

Immunocompetent human airway in vitro models for quantitative chemical assessments
Dr Chiara Maria Mazzanti (Fondazione Pisana per la Scienza ONLUS)

Fluorescence intensity and lifetime imaging microscopy with the phasor approach to assess treatment response and disease progression of glioblastoma patient-derived organoids




More Physiologically Relevant Gut Models

Keynote: TBC

Dr Jan Markus

Dr Adithya Sridhar

Gut organoid monolayer model for infectious diseases research



17:30 DAY 1 FINISH


EVENING - Gala Dinner at Cardiff Castle

Wednesday 5th June

9:30am: DAY 2 BEGINS

Novel models for studying neurological diseases


Dr Prospero Civita (University of Portsmouth)

Towards  a 3D all human in vitro model of glioblastoma multiforme for drug screening: glioblastoma and astrocyte interactions?

Keynote: Professor Roxana O Carare (University of Southampton)

Using quasi-vivo as a system for testing new therapeutic targets in Alzheimer’s disease




In Vitro Models for Animal Replacement

KEYONTE: DR Helena Kanderova (SETOX)

Dr Jan Turner (Safer Medicines Trust)

Human relevant in vitro models – barriers, initiatives and progress towards replacing animal methods in drug discovery

Dr Pascale Guillot ( UCL)

Replacing the use of animals to study bone fragility



12:40: LUNCH


13:40pm: START

Developments within In Vitro cancer research

KEYNOTE: Professor Stephen Evans (University of Leeds)

Cells Under Stress: Microfluidic Determination of Single Cell Behavior and it's Potential for Aiding Diagnosis and Treatment.

Dr Dania Movia (Trinity College Dublin)

Multilayered Cultures of NSCLC cells grown at the Air-Liquid Interface allow the efficacy testing of inhaled anti-cancer drugs

Dr Karen Pilkington (University of Portsmouth)

Interim findings from the SAToRI-BTR (A Systematic Approach To Review of In vitro models in Brain Tumour Research) project.

KEYNOTE: Professor John Greenman (University of Hull)

Patient tissue on chip – a personalized medicine option?




KEYNOTE: Professor Trevor Dale (University of Cardiff)

The practical challenges of using organoids in drug discovery

Dr Suzanne Randle (AstraZeneca, UK)

Recent developments in in vitro models to assess haemtox risk of novel cancer therapeutics

Dr Beate Rinner (Medizinische Universität Graz)

Metastatic melanoma during pregnancy - MUG-Mel3 cell line - an in vitro model




Register today